Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04077762

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access SIte Complication Reduction in Cardiac Catheterization (REBIRTH)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
3,266 (estimated)
Sponsor
Minneapolis Heart Institute Foundation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial infarction undergoing cardiac catheterization. Subjects will be randomized 1:1 into 2 treatment groups: radial access and state-of-the-art femoral access. Randomization will be performed in blocks of 50 per site. Similarly, a second sub-randomization will be performed in the femoral access group into use of 18 vs 21 gauge needles, also in a 1:1 fashion.

Conditions

Interventions

TypeNameDescription
PROCEDURERadial AccessRadial Access
PROCEDUREState-of-the-art femoral access with 18 gauge needleState-of-the-art femoral access with 18 gauge needle
PROCEDUREState-of-the-art femoral access with 21 gauge needleState-of-the-art femoral access with 21 gauge needle. For patients randomized to micropuncture (21G) the micropuncture wire must be advanced under fluoroscopy to avoid inadvertent wiring of side-branches.

Timeline

Start date
2019-11-15
Primary completion
2027-08-19
Completion
2028-08-19
First posted
2019-09-04
Last updated
2025-01-24

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04077762. Inclusion in this directory is not an endorsement.